Literature DB >> 11888590

Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip.

Nicola Cherry, Mike Mackness, Paul Durrington, Andrew Povey, Martin Dippnall, Ted Smith, Bharti Mackness.   

Abstract

Human serum paraoxonase (PON1) hydrolyses diazinonoxon, the active metabolite of diazinon, which is an organophosphate used in sheep dip. In a case-referent study, 175 farmers with ill health that they attributed to sheep dip nominated 234 referent farmers who also dipped sheep and whom they believed to be in good health. We calculated odds ratios for polymorphisms in PON1 at positions 192 and 55, and for PON1 activity with diazinonoxon as substrate. Cases were more likely than referents to have at least one R allele at position 192 (glutamine to arginine aminoacid substitution; odds ratio 1.93, 95% CI 1.24-3.01), both alleles of type LL (1.70, 1.07-2.68) at position 55, and to have diazoxonase activity below normal median (1.77, 1.18-2.67). Our results support the hypothesis that organophosphates contribute to the reported ill health of people who dip sheep.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888590     DOI: 10.1016/s0140-6736(02)07847-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Gulf War syndrome revisited.

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 2.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

Review 3.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

Review 4.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

Authors:  George Davey Smith; Shah Ebrahim
Journal:  BMJ       Date:  2005-05-07

Review 5.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

6.  Acute and repeated effects of three organophosphorus pesticides on the acquisition and retention of an instrumental learning task in rats.

Authors:  Pedro A Geraldi; Jose M Delgado-Garcia; Agnes Gruart
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

7.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

8.  The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women's Heart and Health Study.

Authors:  Debbie A Lawlor; Ian N M Day; Tom R Gaunt; Lesley J Hinks; Nick Timpson; Shah Ebrahim; George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2007-01       Impact factor: 3.710

Review 9.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

Review 10.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.